Il Nostro Contributo Alla Biochimica Della Cancerogenesi Vescicale

Ekman B. , Strömbeck J. P. : Demonstration of tumorigenic decomposition products of 2,3-azotoluene. Acta Physiol. Scand., 14: 43–50: 1947.

Scott W. W. , Boyd H. L. : A study of the carcinogene effect of betanaphtylamine on the normal and substituted isolated sigmoid loop bladder of dogs. J. Urol., 70: 914–925: 1953.

McDonald D. F. , Lund R. R. : The role of the urine in vesical neoplasm. 1. Experimental confirmation of the urogenous theory of pathogenesis. J. Urol., 71: 560–570: 1954.

Clavson D. B. : A working hypothesis for the mode of carcinogenesis of aromatic amines. Brit. J. Cancer, 7: 460: 1953.

Brown R. R. , Price J. M. , Wear J. B. : The metabolism of tryptophan in bladder tumor patients. Proc. Am. Ass. Cancer Res., 2: 7: 1955.

Boyland E. , Williams D. C. : The estimation of tryptophan metabolites in the urine of patients with cancer of the bladder. Biochem. J., 60: 5: 1955.

Boyland E. , Williams D. C. : The metabolism of tryptophan in patients suffering from cancer of the bladder. Biochem. J., 64: 578: 1956.

Fedele L. , Tancredi F. , Riccardi I. : Sulla presenza di metaboliti del triptofano nelle urine di individui affetti da tumori della vescica urinaria. Atti Soc. it. Urol., 32: 92–94: 1959.

Prick J. M. : Disorders of tryptophan metabolism. Univ. Michigan Med. Bull., 24: 461–485: 1958.

Benassi C. A. , Perissinotto B. : Eliminazione di prodotti del metabolismo del triptofano (via chinurenina) in soggetti affetti da tumori vescicali. V^a Jornadas Bioquimicas Latinas. Barcelona, 21-24 maggio 1959.

Benassi C. A. , Perissinotto B. : Alcuni aspetti qualitativi e quantitativi del metabolismo del triptofano (via chinurenina) in situazioni patologiche umane: tumori della vescica. Boll. Soc. Ital. Biol. Sper., 35: fasc. 24 bis: 1959.

Benassi C. A. , Perissinotto B. , Allegri G. : The metabolism of tryptophan in patients with bladder cancer and other urological diseases. Clin. Chim. Acta, 8: 822–831: 1963.

Auricchio S. , Quagliariello K. : Ricerche sperimentali e cliniche sui rapporti fra biosintesi dell'acido nicotinico e cancro della vescica. Biochimica applicata, 5: 409–422: 1958.

Musajo L. , Benassi C. A. , Parpajola : Excretion and isolation of kynurenine and 3-hydroxykynurenine from human pathological urine. Clin. Chim. Acta, 1: 229: 1956.

Allen M. J. , Boyland K. , Dukes C. E. , Horning E. S. , Watson J. G. : Cancer of the urinary bladder induced in mice with metabolites of aromatic amines and tryptophan. Brit. J. Cancer, 11: 212–228: 1957.

Clayson D. B. : Chemical carcinogenesis. Churchill, London 1962, pagg. 227–228.

Boyland E. : The biochemistry of bladder cancer. C. C. Thomas, Springfield 1963, pag. 65.

Bryan G. T. , Brown R. R. , Price J. M. : Mouse bladder carcinogenity of certain tryptophan metabolites and other aromatic nitrogen compound suspended in cholesterol. Cancer Res., 24: 590–602: 1964.

Ball J. K. , Field W. E. H. , Roe F. J. C. , Walters H. : The carcinogenic and co-carcinogenic effects of paraffin wax pellets and glass beads in mouse bladder. Brit. J. Urol., 36: 225–237: 1964.

Ehrhart H. , Georgh A. , Stanislawski K. : Untersuchungen über experimentelle Leukämien. Über die leukämogene Wirkung von 3-Hydroxyanthranilicsaüre bei RFH-Mäusen. Klin. Wschr., 37: 1053–1059: 1959.

Shiba S. , Terawaki A. , Tomiyana Y. : Liver kynunerinase activity of tumor bearing animals. Biken J., 6: 17–20: 1963.

Hankes L. V. , Schmaeller A. , Stoner R. D. : Metabolism of 3-hydroxyanthranilic acid labeled with carbon-14-carboxyl in normal and neoplastic mice. Nature (London), 200/4907: 676–677: 1963.

Kizer D. E. : Precancerous changes in the activity of enzymes associated with tryptophan metabolism and their relevancy to hepatocarcinogenesis. Ann. N. Y. Acad. Sci., 103: 1127–1136: 1963.

Pamuku A. M. : Tumours of the urinary bladder in cattle with special reference to etiology and histogenesis, in Symposium on Cancer of the urinary bladder. S. Karger, Basilea & New York 1963. pagg. 79–80.

Pamuku A. M. , Brown R. R. , Price J. M. : Tryptophan metabolites in the urine of turkish cows with urinary bladder cancer. Cancer Res., 19: 321–325: 1959.

Price J. M. , Brown R. R. : Studies on the etiology of carcinoma of the urinary bladder. in Symposium on Cancer of the urinary bladder. S. Karger, Basilea & New York, pagg. 166–170.

Quagliariello G. : Scienza dell'alimentazione. Idelson, 2^a ed., Napoli 1953.

Wiss O. , Weber F. : Biochemical Pathology of vitamin B _R deficiency. in Vitamins and Hormones, vol. 22, pagg. 495–501. Academic Press, New York & London 1964.

Ito K. , Nakahara I. , Sakamoto Y. : Studies on Vitamin B _R metabolism of cancer cells and tumor-bearing rat liver. I. Enzyme activities related to vitamin B _R metabolism. Gann, 55: 373–378: 1964.

Berndt H. , Hiller I. : Vitamin B₆-Mangel bei malignen Tumoren und der Einfluss der Strahlentherapie. Strahlentherapie, 118: 293–298: 1962.

Wiseman M. H. , Kalant N. , Hoffman M. M. : Tryptophan metabolism in normal and diabetics subjects. J. Lab. Clin. Med., 52: 27–33: 1958.

Sorrentino F. : Nuove vie di ricerca nella biochimica dei tumori vescicali. Riforma med., 73: 670–675: 1959.

Sorrentino F. : Processi biochimici nella cancerogenesi vescicale. Atti Soc. it. Urol., 32: 109–111: 1959.

Beetham W. Jr. , Fischer S. , Schroeloher R. : Tryptophan metabolite excretion in connective tissue diseases dimostrating a difference between rheumatoid spondylitis and rheumatoid arthritis. Proc. Soc. Exp. Biol. Med., 117: 756–759: 1964.

Michael A. F. , Drummond K. N. , Doeden D. , Anderson J. A. , Good R. A. : Tryptophan metabolism in man. J. Clin. Investig., 43: 1730–1746: 1964.

Mainardi L. , Tenconi L. T. : Contributo allo studio dei metaboliti della linea triptofano-acido nicotinico in rapporto al sesso. Acta Vitamin., 18: 249–253: 1964.

Brown R. R. , Thornton H. J. , Price J. M. : The effect of vitamin supplementation on the urinary excretion of tryptophan metabolites by pregnant women. J. Clin. Investig., 40: 617–623: 1961.

Hueper W. C. : Environmental and industrial cancers of the urinary bladder in the U.S.A. in Symposium on Cancer of the urinary bladder. S. Karger, Basilea & New York 1963, pagg. 67–78.

Denoix P. F. , Schwarz D. : Bull. Assoc. Franç. Cancer, 43: 387–393: 1956, citato da Kerr (46).

Hammond E. C. , Horn D. : J.A.M.A., 166: 294: 1958, citato da Kerr (46).

Lockwood K. : On the etiology of bladder tumors in Kobenhavn Frederiksberg. in Symposium on Cancer of the urinary bladder. S. Karger, Basilea & New York, 1963, pagg. 90–92.

Ermala P. , Holsti R. L. : Cancer Res., 16: 490–495: 1956, citato da Wynder e Hoffmann (45).

Bonser G. M. : in « The morphological precursor of cancer». Perugia 1962, pagg. 460–462, citata da Wynder e Hoffmann (45).

Wynder E. L. , Hoffmann D. : Experimental tobacco carcinogenesis, in «Advances in Cancer Research», vol. 8, pagg. 249–453. Academic Press, New York & Londra 1964.

Kerr W. K. , Barkin M. , Levers P. E. , Woo S. K.-C. , Menczyk Z. : The effect of cigarette smoking on bladder carcinogens in man. Cariaci. Med. Ass. J., 93: 1–7: 3 luglio 1965.

Boyland E. : The biochemistry of bladder cancer. C. C. Thomas, Springfield1963, pagg. 48–50.

Boyland E. , Manson D. , Sims P. , Williams D. C. : The biochemistry of aromatic amines. The resistence of o-amino-aryl-sulphates to hydrolysis by aryl-sulphatase. Biochem. J., 62: 68: 1956.

Mattea E. : Processi biocchimici nella cancerogenesi vescicale. Relazione al XXXII Congresso della Soc. it. Urol., 1959. Casa Ed. Ambrosiana, Milano 1959.

Boyland E. , Wallace D. M. , Williams D. C. : Urinary enzymes in bladder cancer. Brit. J. Urol., 27: 11–14: 1955.

Boyland E. , Gasson J. E. , Williams D. C. : Enzyme activity in relation to cancer. The urinary β-glucuronidase activity of patients suffering from malignant disease. Brit. J. Cancer, 11: 120: 1957.

Boyland E. : Aetiology and biochemistry of cancer of the urinary bladder, in Wallace D. M. Tumors of the bladder. Livingstone, Edimburgo & Londra 1959, pagg. 95–99.

Romano C. , Sorrentino F. : Attività β-glicuronidasica in portatori di neoplasia vescicale dopo cistectomia totale. Urologia, 28: 12–15: 1961.

Kerr W. K. , Barkin M. , D'Aloisio J. , Menczyk Z. : Biochemical factors in the etiology of carcinoma of the bladder. The role of β-glucuronidase. Cancer, 16: 633–638: 1963.

Appert O. , Richterich R. : Die Urin- und Plasma-β-Glucuronidase in ihren Beziehung zum Blasentumor. Urol. int., 20: 206–221: 1965.

Piazza B. , Pavone Macaluso M. : Ricerche sulla β-glicuronidasi nelle urine prelevate mediante cateterismo vescicale ed ureterale in portatori di tumori vescicali ed in soggetti con affezioni urologiche non neoplastiche. Atti Soc. it. Urol., 32: 95–99: 1959.

Comuzzi U. , Ciampi G. , Morelli Gualtierotti M. : Ricerche sulla cancerogenesi vescicale. Rilievi sul significato e sul valore della β-glicuronidasi urinaria nei tumori vescicali. Urologia, 27: 597–604: 1960.

Fripp P. J. : Nature (London), 188: 507: 1960.

Eripp P. J. : Ricerche non pubblicate, citato da Dodge O. G.: Tumours of the bladder in Uganda Africans, in «Symposium on Cancer of the Urinary bladder». S. Karger, Basilea & New York 1963, pag. 33.

Di Somma A. A. : The constitution of conjugated phenolphtalein formed in animal body. J. Biol. Chem., 133: 277–284: 1940.

Sorrentino F. , Romano C. : Actual urinary β-glucuronidase activity and cancer of the bladder. Urol. int., 11: 232–239: 1961.

Sorrentino F. , Romano C. : Tolerance test with phenolphtalein: study of its detoxication and of urinary β-glucuronidase activity «in vivo» in patients with bladder neoplasm. Urol. int., 12: 328–338: 1961.

Pavone Macaluso M. , Di Donna D. , Palazzolo A. M. : Attività β-glicuronidasica urinaria in campioni di popolazione (siciliana e libica) aventi diversa frequenza di insorgenza di neoplasie vescicali. Boll. Soc. it. Biol. sper., 38: 386–388: 1962.

Ohkubo T. , Sonoda T. , Kusunoki T. : Biochemical and istochemical studies of the β-glucuronidase activity in urology. Urol. int., 7: 167–183: 1958.

Melicow M. M. , Uson A. C. , Lipton R. : New horizons in therapy of bladder tumours. The possible role of enzymes and metabolites in genesis of bladder cancer. A study of β-glucuronidase activity in the urine. N. Y. St. J. Med., 61: 2228–2234: 1961.

Lewis F. J. W. , Plaice C. H. J. : Urinary β-glucuronidasc activity in cancer of the bladder and other disease. Brit. J. Cancer, 14: 106: 1960.

Haije W. G. , van Der Werf-Messing B. H. P. : Some investigations into the origin of the β-glucuronidase activity in the urine of patients with cancer of the bladder. Brit. J. Cancer, 16: 570–576: 1962.

Boyland E. , Davies : citati da Boyland (71) come in preparazione, ma il lavoro non fu pubblicato a quanto ci consta, ed in Boyland (47) i dati sono attribuiti al solo Davies come comunicazione personale.

Hradec E. A. , Petrik R. , Pezlarova J. : Activity of β-glucuronidase in cases of bladder neoplasm. J. Urol., 94: 430–435: 1965.

Staumbaugh R. , Weinhouse S. : Urinary enzymes and their diagnostic value in human cancer. in Advances in Cancer Research, vol. 9 pagg. 1–45, Academic Press, New York e Londra 1965.

Boyland E. : Urinary metabolites as causative agents in bladder cancer. in Symposium on Cancer of the urinary bladder. S. Karger, Basilea & New York, 1963 pagg. 27–29.

Boyland E. , Wallace D. M. , Williams D. C. : Enzyme activity in relation to cancer. Inhibition of urinary β-glucuronidase of patients with cancer of the bladder by oral administration of 1: 4-saccharolactome and related compounds. Brit. J. Cancer, 11: 570–589: 1957.

Boyland E. : The biochemistry of bladder cancer. C. C. Thomas, Springfield, 1963 pagg. 71–75.

Boyland E. , Wallace D. M. , Avis P. R. D. , Kinder C. M. : Altemped prophylaxis of bladder cancer with 1-4 glucosaccharolactone. Brit. J. Urol., 36: 563–569: 1964.

Bradley H. J. Jr. : Effects of β-glucuronidase inhibitor and methylcholantrene on the induction of bladder tumours in rats. J. Urol., 88: 626–628: 1962.

Boyland E. , Kinder C. H. , Manson D. , Wallace D. M. : An attempt to prevent the induction of bladder cancer in dogs with 1-4 glucosaccharolactone. Investig. Urol., 2: 439–445: 1965.

Running W. F. , Curtis M. R. , Maun M. E. : The effect of added dietary tryptophane on the occurence of 2-acetylaminofluorene-induced liver and bladder cancer in rats. Cancer Res., 10: 454–459: 1950.

Dunning W. F. , Curtis M. R. : The role of indole in the incidence of 2-acetylaminofluorene-induced bladder cancer in rats. Proc. Soc. Exp. Biol. Med., 99: 91–95: 1958.

Dyer H. M. , Morris H. P. : An effect of N-2-fluorenylacetamide on the metabolism of tryptophan in rats. J. Natl. Cancer Inst., 26: 315–329: 1961.

Melicow M. M. , Uson A. C. , Price T. D. : Bladder tumor induction in rats fed 2-acetamidofluorene (s-AAF) and pvridoxine deficient diet. J. Urol., 91: 520–529: 1964.

Boyland E. , Harris J. , Horning E. S. : The induction of carcinoma of the bladder in rats with acetamidofluorene. Brit. J. Cancer, 8: 647: 1954.

McDonald J. M. , Oyasu R. , Hass G. M. : The relation of liver neoplasm to bladder tumours produced by 2-acetylaminofluorene. J. Urol., 87: 381–390: 1962.

Sorrentino F. : Tumori vescicali sperimentali da dieta ricca in banane. Urologia, 28: 16–32: 1961.

Abul-Fadl M. A. M. , Khalafallah A. S. : Studies on the urinary excretion of certain tryptophan metabolites in bilharziosis and its possible relation to bladder cancer in Egypt. Brit. J. Cancer, 15: 479–482: 1961.

Trout G. E. , Gillman J. , Prates M. D. : The effect of schistosomiasis on the urinary excretion of tryptophan metabolites. S. Afr. J. Med. Sci., 25: 150–151: 1960.

Dodge O. G. : Tumours of the bladder and urethra associated with urinary retention in Uganda Africans. Cancer, 17: 1433–1436: 1964.

Fripp P. J. : Bilharziasis and bladder cancer. Brit. J. Cancer, 19: 292–296: 1965.

Crawford M. A. : Comunicazione personale.

Sorrentino F. , Romano C. : 3-indolacetic acid (IAA) and 5-hydroxy-indolacetic acid (5HIAA) excretion in patients with vesical tumours. Urol. int., 19: 259–270: 1965.

Boyland E. , Gasson J. E. , Williams D. C. : 5-hydroxy-triptamine excretion in patients with carcinoma of the larynx and bronchus. Lancet, 2: 975–976: 1956.

Ziliotto G. R. : Sul reperto di tumori epiteliali della vescica concomitante a neoformazioni localizzate in altri distretti. Atti Soc. it. Cancerologia 2° Symposium 1960 pagg. 470–480.

Dargent M. , Colon J. , Nahas V. : Documents anatomocilniques concernent l'association cancer de l'hypopharynx et cancers des voies urinaires excrétrices. Bull. Cancer, 49: 169–184: 1962.

Sorrentino F. , Romano C. : Sulla associazione neoplasie epiteliali vescicali e neoplasie dell'ipofaringe e laringe. in corso di stampa su «Urologia 1966».

Mattea E. : Tumori della vescica in lavoratori delle amine aromatiche. Casa Ed. Ambrosiana, Milano 1958, pagg. 50–58.

Clayson D. B. : Chemical carcinogenesis. Churchill, Londra 1962, pagg. 290–314.

Gowenlock A. H. , Campbell A. C. P. , Platt D. S. : Biochemical interrelationships between bronchial adenomas and carcinomas. Proc. Ass. Clin. Biochem., 2: 208–209: 1963.

Leppanev V. V. E. , Oka M. : Metabolism of tryptophan in cancer of varous sites. Ann. Med. exp. Fenn., 41: 123–127: 1963.

Raushenbak M. O. , Zharova E. J. , Ivanova V. D. , Nemenova N. M. , Prostasova T. G. , Marozovshaja L. M. (testo in russo). Probl. Gemat., 6-10: 3–8: 1961.

Braun A. C. , Wood H. N. : The plant tumor problem. in Advances in Cancer Reesarch vol. 6 pagg. 81–109 (1961) Academic Press, New York & Londra.

Lettre H. e Endo H. : Zur Wirkung von Kinetin und Analogen auf tierische Zellen. Naturwiss., 43: 84–85: 1956.

Laborit H. : Physiologie humaine. Masson éd., Parigi 1961, pagg. 423–424.